Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1470

1.

Hypokalemia and hearing loss in a 3-year-old boy: Answers.

Aksoy OY, Cayci FS, Ceylaner S, Tokgoz SA, Kaplan G, Bayrakci US.

Pediatr Nephrol. 2019 Oct 30. doi: 10.1007/s00467-019-04383-8. [Epub ahead of print] No abstract available.

PMID:
31667619
2.

Hypokalemia and hearing loss in a 3-year-old boy: Questions.

Aksoy OY, Cayci FS, Ceylaner S, Tokgoz SA, Kaplan G, Bayrakci US.

Pediatr Nephrol. 2019 Oct 30. doi: 10.1007/s00467-019-04379-4. [Epub ahead of print]

PMID:
31667618
3.

BIOLOGICAL THERAPY PENETRATION FOR INFLAMMATORY BOWEL DISEASE IN LATIN AMERICA: CURRENT STATUS AND FUTURE CHALLENGES.

Quaresma AB, Coy CSR, Damião AOMC, Kaplan GG, Kotze PG.

Arq Gastroenterol. 2019 Sep 30;56(3):318-322. doi: 10.1590/S0004-2803.201900000-59. eCollection 2019.

4.

Tuberculosis control in crisis-causes and solutions.

Kaplan G.

Prog Biophys Mol Biol. 2019 Oct 15. pii: S0079-6107(19)30189-0. doi: 10.1016/j.pbiomolbio.2019.10.001. [Epub ahead of print] Review.

PMID:
31626823
5.

The Role of Bowel Ultrasound in Detecting Subclinical Inflammation in Pregnant Women with Crohn's Disease.

Leung Y, Shim HH, Wilkens R, Tanyingoh D, Afshar EE, Sharifi N, Pauls M, Novak KL, Kaplan GG, Panaccione R, Wilson SR, Seow CH.

J Can Assoc Gastroenterol. 2019 Dec;2(4):153-160. doi: 10.1093/jcag/gwy062. Epub 2018 Oct 24.

6.

Global smoking trends in inflammatory bowel disease: A systematic review of inception cohorts.

Thomas T, Chandan JS, Li VSW, Lai CY, Tang W, Bhala N, Kaplan GG, Ng SC, Ghosh S.

PLoS One. 2019 Sep 23;14(9):e0221961. doi: 10.1371/journal.pone.0221961. eCollection 2019.

7.

Practice patterns and predictors of prophylactic endoscopic clip usage during polypectomy.

Forbes N, Hilsden RJ, Kaplan GG, James MT, Lethebe C, Maxwell C, Heitman SJ.

Endosc Int Open. 2019 Sep;7(9):E1051-E1060. doi: 10.1055/a-0953-1787. Epub 2019 Aug 29.

8.

Insights into the role of cannabis in the management of inflammatory bowel disease.

Picardo S, Kaplan GG, Sharkey KA, Seow CH.

Therap Adv Gastroenterol. 2019 Sep 3;12:1756284819870977. doi: 10.1177/1756284819870977. eCollection 2019. Review.

9.

Evolving Epidemiology of IBD.

Windsor JW, Kaplan GG.

Curr Gastroenterol Rep. 2019 Jul 23;21(8):40. doi: 10.1007/s11894-019-0705-6. Review.

PMID:
31338613
10.

Acute Venous Thromboembolism Risk Highest Within 60 Days After Discharge From the Hospital in Patients With Inflammatory Bowel Diseases.

Faye AS, Wen T, Ananthakrishnan AN, Lichtiger S, Kaplan GG, Friedman AM, Lawlor G, Wright JD, Attenello FJ, Mack WJ, Lebwohl B.

Clin Gastroenterol Hepatol. 2019 Jul 20. pii: S1542-3565(19)30772-4. doi: 10.1016/j.cgh.2019.07.028. [Epub ahead of print]

PMID:
31336196
11.

The impact of surgical therapies for inflammatory bowel disease on female fertility.

Lee S, Crowe M, Seow CH, Kotze PG, Kaplan GG, Metcalfe A, Ricciuto A, Benchimol EI, Kuenzig ME.

Cochrane Database Syst Rev. 2019 Jul 23;7:CD012711. doi: 10.1002/14651858.CD012711.pub2.

PMID:
31334846
12.

The Impact of Inflammatory Bowel Disease in Canada 2018: IBD Research Landscape in Canada.

Rose KL, Sherman PM, Cooke-Lauder J, Mawani M, Benchimol EI, Kaplan GG, Bernstein CN, Bitton A, Murthy SK, Nguyen GC, Lee K.

J Can Assoc Gastroenterol. 2019 Feb;2(Suppl 1):S81-S91. doi: 10.1093/jcag/gwy057. Epub 2018 Nov 2.

13.

The Impact of Inflammatory Bowel Disease in Canada 2018: Extra-intestinal Diseases in IBD.

Bernstein CN, Benchimol EI, Bitton A, Murthy SK, Nguyen GC, Lee K, Cooke-Lauder J, Kaplan GG.

J Can Assoc Gastroenterol. 2019 Feb;2(Suppl 1):S73-S80. doi: 10.1093/jcag/gwy053. Epub 2018 Nov 2.

14.

The Impact of Inflammatory Bowel Disease in Canada 2018: IBD in Seniors.

Nguyen GC, Targownik LE, Singh H, Benchimol EI, Bitton A, Murthy SK, Bernstein CN, Lee K, Cooke-Lauder J, Kaplan GG.

J Can Assoc Gastroenterol. 2019 Feb;2(Suppl 1):S68-S72. doi: 10.1093/jcag/gwy051. Epub 2018 Nov 2.

15.

The Impact of Inflammatory Bowel Disease in Canada 2018: Children and Adolescents with IBD.

Carroll MW, Kuenzig ME, Mack DR, Otley AR, Griffiths AM, Kaplan GG, Bernstein CN, Bitton A, Murthy SK, Nguyen GC, Lee K, Cooke-Lauder J, Benchimol EI.

J Can Assoc Gastroenterol. 2019 Feb;2(Suppl 1):S49-S67. doi: 10.1093/jcag/gwy056. Epub 2018 Nov 2.

16.

The Impact of Inflammatory Bowel Disease in Canada 2018: Quality of Life.

Jones JL, Nguyen GC, Benchimol EI, Bernstein CN, Bitton A, Kaplan GG, Murthy SK, Lee K, Cooke-Lauder J, Otley AR.

J Can Assoc Gastroenterol. 2019 Feb;2(Suppl 1):S42-S48. doi: 10.1093/jcag/gwy048. Epub 2018 Nov 2.

17.

The Impact of Inflammatory Bowel Disease in Canada 2018: Indirect Costs of IBD Care.

Kuenzig ME, Lee L, El-Matary W, Weizman AV, Benchimol EI, Kaplan GG, Nguyen GC, Bernstein CN, Bitton A, Lee K, Cooke-Lauder J, Murthy SK.

J Can Assoc Gastroenterol. 2019 Feb;2(Suppl 1):S34-S41. doi: 10.1093/jcag/gwy050. Epub 2018 Nov 2.

18.

The Impact of Inflammatory Bowel Disease in Canada 2018: Direct Costs and Health Services Utilization.

Kuenzig ME, Benchimol EI, Lee L, Targownik LE, Singh H, Kaplan GG, Bernstein CN, Bitton A, Nguyen GC, Lee K, Cooke-Lauder J, Murthy SK.

J Can Assoc Gastroenterol. 2019 Feb;2(Suppl 1):S17-S33. doi: 10.1093/jcag/gwy055. Epub 2018 Nov 2.

19.

The Impact of Inflammatory Bowel Disease in Canada 2018: Epidemiology.

Kaplan GG, Bernstein CN, Coward S, Bitton A, Murthy SK, Nguyen GC, Lee K, Cooke-Lauder J, Benchimol EI.

J Can Assoc Gastroenterol. 2019 Feb;2(Suppl 1):S6-S16. doi: 10.1093/jcag/gwy054. Epub 2018 Nov 2.

20.

The Impact of Inflammatory Bowel Disease in Canada 2018: A Scientific Report from the Canadian Gastro-Intestinal Epidemiology Consortium to Crohn's and Colitis Canada.

Benchimol EI, Bernstein CN, Bitton A, Murthy SK, Nguyen GC, Lee K, Cooke-Lauder J, Siddiq S, Windsor JW, Carroll MW, Coward S, El-Matary W, Griffiths AM, Jones JL, Kuenzig ME, Lee L, Mack DR, Mawani M, Otley AR, Singh H, Targownik LE, Weizman AV, Kaplan GG.

J Can Assoc Gastroenterol. 2019 Feb;2(Suppl 1):S1-S5. doi: 10.1093/jcag/gwy052. Epub 2018 Nov 2.

21.

Routine Prophylactic Endoscopic Clipping Is Not Efficacious in the Prevention of Delayed Post-Polypectomy Bleeding: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Forbes N, Frehlich L, James MT, Hilsden RJ, Kaplan GG, Wilson TA, Lorenzetti DL, Tate DJ, Bourke MJ, Heitman SJ.

J Can Assoc Gastroenterol. 2019 Aug;2(3):105-117. doi: 10.1093/jcag/gwy033. Epub 2018 Jul 20.

22.

Preoperative Ustekinumab Treatment Is Not Associated With Increased Postoperative Complications in Crohn's Disease: A Canadian Multi-Centre Observational Cohort Study.

Shim HH, Ma C, Kotze PG, Seow CH, Al-Farhan H, Al-Darmaki AK, Pang JXQ, Fedorak RN, Devlin SM, Dieleman LA, Kaplan GG, Novak KL, Kroeker KI, Halloran BP, Panaccione R.

J Can Assoc Gastroenterol. 2018 Sep;1(3):115-123. doi: 10.1093/jcag/gwy013. Epub 2018 May 10.

23.

Author Correction: The wide utility of rabbits as models of human diseases.

Esteves PJ, Abrantes J, Baldauf HM, BenMohamed L, Chen Y, Christensen N, González-Gallego J, Giacani L, Hu J, Kaplan G, Keppler OT, Knight KL, Kong XP, Lanning DK, Le Pendu J, de Matos AL, Liu J, Liu S, Lopes AM, Lu S, Lukehart S, Manabe YC, Neves F, McFadden G, Pan R, Peng X, de Sousa-Pereira P, Pinheiro A, Rahman M, Ruvoën-Clouet N, Subbian S, Tuñón MJ, van der Loo W, Vaine M, Via LE, Wang S, Mage R.

Exp Mol Med. 2019 Jul 4;51(7):71. doi: 10.1038/s12276-019-0252-0.

24.

Progression of Inflammatory Bowel Diseases Throughout Latin America and the Caribbean: a Systematic Review.

Kotze PG, Underwood FE, Damião AOMC, Ferraz JGP, Saad-Hossne R, Toro M, Iade B, Bosques-Padilla F, Teixeira FV, Juliao-Banos F, Simian D, Ghosh S, Panaccione R, Ng SC, Kaplan GG.

Clin Gastroenterol Hepatol. 2019 Jun 25. pii: S1542-3565(19)30668-8. doi: 10.1016/j.cgh.2019.06.030. [Epub ahead of print]

25.

The Simple Pediatric Activity Ultrasound Score (SPAUSS) for the Accurate Detection of Pediatric Inflammatory Bowel Disease.

Kellar A, Wilson S, Kaplan G, DeBruyn J, Tanyingoh D, Novak KL.

J Pediatr Gastroenterol Nutr. 2019 Jul;69(1):e1-e6. doi: 10.1097/MPG.0000000000002298.

PMID:
31232886
26.

The Effect of Initiation of Anti-TNF Therapy on the Subsequent Direct Health Care Costs of Inflammatory Bowel Disease.

Targownik LE, Benchimol EI, Witt J, Bernstein CN, Singh H, Lix L, Tennakoon A, Zubieta AA, Coward S, Jones J, Kuenzig E, Murthy SK, Nguyen GC, Peña-Sánchez JN, Kaplan G.

Inflamm Bowel Dis. 2019 Jun 18. pii: izz063. doi: 10.1093/ibd/izz063. [Epub ahead of print]

PMID:
31211836
27.

Reduction in surgical stoma rates in Crohn's disease: a population-based time trend analysis.

Ma C, Almutairdi A, Tanyingoh D, Seow CH, Novak KL, Lu C, Panaccione R, Kaplan GG, Kotze PG.

Colorectal Dis. 2019 Nov;21(11):1279-1287. doi: 10.1111/codi.14731. Epub 2019 Jul 5.

PMID:
31206974
28.

Introduction of anti-TNF therapy has not yielded expected declines in hospitalisation and intestinal resection rates in inflammatory bowel diseases: a population-based interrupted time series study.

Murthy SK, Begum J, Benchimol EI, Bernstein CN, Kaplan GG, McCurdy JD, Singh H, Targownik L, Taljaard M.

Gut. 2019 Jun 12. pii: gutjnl-2019-318440. doi: 10.1136/gutjnl-2019-318440. [Epub ahead of print]

29.

Ultrasensitive Ebola Virus Antigen Sensing via 3D Nanoantenna Arrays.

Zang F, Su Z, Zhou L, Konduru K, Kaplan G, Chou SY.

Adv Mater. 2019 Jul;31(30):e1902331. doi: 10.1002/adma.201902331. Epub 2019 Jun 6.

PMID:
31168856
30.

Reply to Das et al., "TIM1 (HAVCR1): an Essential 'Receptor' or an 'Accessory Attachment Factor' for Hepatitis A Virus?"

Costafreda MI, Kaplan G.

J Virol. 2019 May 15;93(11). pii: e02040-18. doi: 10.1128/JVI.02040-18. Print 2019 Jun 1. No abstract available.

PMID:
31092685
31.

The globalization of inflammatory bowel disease: the incidence and prevalence of inflammatory bowel disease in Brazil.

Quaresma AB, Kaplan GG, Kotze PG.

Curr Opin Gastroenterol. 2019 Apr 9. doi: 10.1097/MOG.0000000000000534. [Epub ahead of print]

PMID:
30973356
32.

Road to pediatric urology subcertification: a 25-year journey.

Rushton HG, Kaplan GW, Mitchell ME, Caldamone AA.

J Pediatr Urol. 2019 Apr;15(2):108-111. doi: 10.1016/j.jpurol.2019.02.017. Epub 2019 Mar 16. No abstract available.

PMID:
30967357
33.

Appropriate Therapeutic Drug Monitoring of Biologic Agents for Patients With Inflammatory Bowel Diseases.

Papamichael K, Cheifetz AS, Melmed GY, Irving PM, Vande Casteele N, Kozuch PL, Raffals LE, Baidoo L, Bressler B, Devlin SM, Jones J, Kaplan GG, Sparrow MP, Velayos FS, Ullman T, Siegel CA.

Clin Gastroenterol Hepatol. 2019 Aug;17(9):1655-1668.e3. doi: 10.1016/j.cgh.2019.03.037. Epub 2019 Mar 27.

34.

Depression in inflammatory bowel disease: risk factor, prodrome or extraintestinal manifestation? Reply from authors.

Frolkis AD, Vallerand IA, Patten SB, Kaplan GG.

Gut. 2019 Mar 20. pii: gutjnl-2019-318650. doi: 10.1136/gutjnl-2019-318650. [Epub ahead of print] No abstract available.

PMID:
30894399
35.

The Unsolved Link of Genetic Markers and Crohn's Disease Progression: A North American Cohort Experience.

O'Donnell S, Borowski K, Espin-Garcia O, Milgrom R, Kabakchiev B, Stempak J, Panikkath D, Eksteen B, Xu W, Steinhart AH, Kaplan GG, McGovern DPB, Silverberg MS.

Inflamm Bowel Dis. 2019 Aug 20;25(9):1541-1549. doi: 10.1093/ibd/izz016.

PMID:
30801121
36.

Changing trends in coding for depression among the UK IBD population: reply from authors.

Vallerand I, Frolkis AD, Patten S, Kaplan GG.

Gut. 2019 Feb 21. pii: gutjnl-2019-318405. doi: 10.1136/gutjnl-2019-318405. [Epub ahead of print] No abstract available.

PMID:
30792245
37.

Efficacy of biological drugs in short-duration versus long-duration inflammatory bowel disease: a protocol for a systematic review and an individual-patient level meta-analysis of randomised controlled trials.

Ben-Horin S, Zhao Y, Guo J, Mao R, Novack L, Sergienko R, Zhang J, Kobayashi T, Hibi T, Chowers Y, Colombel JF, Peyrin-Biroulet L, Kaplan G, Chen MH.

BMJ Open. 2019 Jan 25;9(1):e024222. doi: 10.1136/bmjopen-2018-024222.

38.

Truth-telling and doctor-assisted death as perceived by Israeli physicians.

Velan B, Ziv A, Kaplan G, Rubin C, Connelly Y, Karni T, Tal O.

BMC Med Ethics. 2019 Feb 18;20(1):13. doi: 10.1186/s12910-019-0350-5.

39.

Trends in hospitalisation rates for inflammatory bowel disease in western versus newly industrialised countries: a population-based study of countries in the Organisation for Economic Co-operation and Development.

King JA, Underwood FE, Panaccione N, Quan J, Windsor JW, Kotze PG, Ng SC, Ghosh S, Lakatos PL, Jess T, Panaccione R, Seow CH, Ben-Horin S, Burisch J, Colombel JF, Loftus EV Jr, Gearry R, Halfvarson J, Kaplan GG.

Lancet Gastroenterol Hepatol. 2019 Apr;4(4):287-295. doi: 10.1016/S2468-1253(19)30013-5. Epub 2019 Feb 12.

PMID:
30765267
40.

Primary biliary cholangitis patients exhibit MRI changes in structure and function of interoceptive brain regions.

Mosher V, Swain M, Pang J, Kaplan G, Sharkey K, MacQueen G, Goodyear BG.

PLoS One. 2019 Feb 8;14(2):e0211906. doi: 10.1371/journal.pone.0211906. eCollection 2019.

41.

The Simple Pediatric Activity Ultrasound Score (SPAUSS) for the Accurate Detection of Pediatric Inflammatory Bowel Disease.

Kellar A, Wilson S, Kaplan G, deBruyn J, Tanyingoh D, Novak KL.

J Pediatr Gastroenterol Nutr. 2019 Feb 4. doi: 10.1097/MPG.0000000000002298. [Epub ahead of print]

PMID:
30724797
42.

Nationwide estimates and risk factors of hospital readmission in patients with cirrhosis in the United States.

Shaheen AA, Nguyen HH, Congly SE, Kaplan GG, Swain MG.

Liver Int. 2019 May;39(5):878-884. doi: 10.1111/liv.14054. Epub 2019 Feb 25.

PMID:
30688401
43.

Budesonide for the Induction and Maintenance of Remission in Crohn's Disease: Systematic Review and Meta-Analysis for the Cochrane Collaboration.

Kuenzig ME, Rezaie A, Kaplan GG, Otley AR, Steinhart AH, Griffiths AM, Benchimol EI, Seow CH.

J Can Assoc Gastroenterol. 2018 Dec;1(4):159-173. doi: 10.1093/jcag/gwy018. Epub 2018 May 24.

44.

Past and Future Burden of Inflammatory Bowel Diseases Based on Modeling of Population-Based Data.

Coward S, Clement F, Benchimol EI, Bernstein CN, Avina-Zubieta JA, Bitton A, Carroll MW, Hazlewood G, Jacobson K, Jelinski S, Deardon R, Jones JL, Kuenzig ME, Leddin D, McBrien KA, Murthy SK, Nguyen GC, Otley AR, Panaccione R, Rezaie A, Rosenfeld G, Peña-Sánchez JN, Singh H, Targownik LE, Kaplan GG.

Gastroenterology. 2019 Apr;156(5):1345-1353.e4. doi: 10.1053/j.gastro.2019.01.002. Epub 2019 Jan 10.

45.

Systematic review with meta-analysis: review of donor features, procedures and outcomes in 168 clinical studies of faecal microbiota transplantation.

Lai CY, Sung J, Cheng F, Tang W, Wong SH, Chan PKS, Kamm MA, Sung JJY, Kaplan G, Chan FKL, Ng SC.

Aliment Pharmacol Ther. 2019 Feb;49(4):354-363. doi: 10.1111/apt.15116. Epub 2019 Jan 9. Review.

PMID:
30628108
46.

[Ethical standards of physicians in Israel 2018 report of the Chair of the Ethics Bureau of the Israel Medical Association (IMA)].

Karni T, Kaplan G, Ziv A, Connelly Y, Velan B, Tal O.

Harefuah. 2018 Dec;157(12):751-755. Hebrew. No abstract available.

PMID:
30582305
47.

Rural and urban disparities in the care of Canadian patients with inflammatory bowel disease: a population-based study.

Benchimol EI, Kuenzig ME, Bernstein CN, Nguyen GC, Guttmann A, Jones JL, Potter BK, Targownik LE, Catley CA, Nugent ZJ, Tanyingoh D, Mojaverian N, Underwood FE, Siddiq S, Otley AR, Bitton A, Carroll MW, deBruyn JC, Dummer TJ, El-Matary W, Griffiths AM, Jacobson K, Leddin D, Lix LM, Mack DR, Murthy SK, Peña-Sánchez JN, Singh H, Kaplan GG; Canadian Gastro-Intestinal Epidemiology Consortium.

Clin Epidemiol. 2018 Nov 8;10:1613-1626. doi: 10.2147/CLEP.S178056. eCollection 2018.

49.

Upfront Combination Therapy, Compared With Monotherapy, for Patients Not Previously Treated With a Biologic Agent Associates With Reduced Risk of Inflammatory Bowel Disease-related Complications in a Population-based Cohort Study.

Targownik LE, Benchimol EI, Bernstein CN, Singh H, Lix L, Tennakoon A, Leung S, Aviña A, Coward S, Jones J, Kaplan G, Murthy SK, Nguyen GC, Peña-Sánchez JN.

Clin Gastroenterol Hepatol. 2019 Aug;17(9):1788-1798.e2. doi: 10.1016/j.cgh.2018.11.003. Epub 2018 Nov 15.

PMID:
30448599
50.

Frequency of Circulating CD4+Ki67+HLA-DR- T Regulatory Cells Prior to Treatment for Multidrug Resistant Tuberculosis Can Differentiate the Severity of Disease and Predict Time to Culture Conversion.

Ferrian S, Ross M, Conradie F, Vally Omar S, Ismail N, Little F, Kaplan G, Fallows D, Gray CM.

Front Immunol. 2018 Oct 25;9:2438. doi: 10.3389/fimmu.2018.02438. eCollection 2018.

Supplemental Content

Loading ...
Support Center